260 related articles for article (PubMed ID: 20604734)
1. Fenofibrate in the treatment of dyslipidemia associated with HIV infection.
Samineni D; Fichtenbaum CJ
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):995-1004. PubMed ID: 20604734
[TBL] [Abstract][Full Text] [Related]
2. Clinical management considerations for dyslipidemia in HIV-infected individuals.
Kirchner JT
Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112
[TBL] [Abstract][Full Text] [Related]
3. [HIV-infection, HAART (highly-active antiretroviral therapy) and hyperlipidemia].
Hirsch HH; Battegay M
Dtsch Med Wochenschr; 2003 May; 128(19):1051-4. PubMed ID: 12736856
[TBL] [Abstract][Full Text] [Related]
4. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
Rotger M; Bayard C; Taffé P; Martinez R; Cavassini M; Bernasconi E; Battegay M; Hirschel B; Furrer H; Witteck A; Weber R; Ledergerber B; Telenti A; Tarr PE;
Circ Cardiovasc Genet; 2009 Dec; 2(6):621-8. PubMed ID: 20031643
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of high blood cholesterol in patients with coronary heart disease].
Nagai Y; Yamashita S
Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
[No Abstract] [Full Text] [Related]
6. Combination lipid therapy in type 2 diabetes.
Sacks FM; Carey VJ; Fruchart JC
N Engl J Med; 2010 Aug; 363(7):692-4; author reply 694-5. PubMed ID: 20842772
[No Abstract] [Full Text] [Related]
7. Fenofibrate profiled as the fibrate with additional new data, supporting its use with statins in the European Medicines Agency recommendations.
Cardiovasc J Afr; 2011; 22(1):55. PubMed ID: 21298212
[No Abstract] [Full Text] [Related]
8. Coronary heart disease in people infected with HIV.
Malvestutto CD; Aberg JA
Cleve Clin J Med; 2010 Aug; 77(8):547-56. PubMed ID: 20682517
[TBL] [Abstract][Full Text] [Related]
9. Dyslipidemia in HIV-infected individuals.
Sprinz E; Lazzaretti RK; Kuhmmer R; Ribeiro JP
Braz J Infect Dis; 2010; 14(6):575-88. PubMed ID: 21340298
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial.
Ishibashi S; Arai H; Yokote K; Araki E; Suganami H; Yamashita S;
J Clin Lipidol; 2018; 12(1):173-184. PubMed ID: 29203092
[TBL] [Abstract][Full Text] [Related]
11. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
[TBL] [Abstract][Full Text] [Related]
12. Retinopathy progression in type 2 diabetes.
Baum SJ
N Engl J Med; 2010 Nov; 363(22):2172; author reply 2173-4. PubMed ID: 21105808
[No Abstract] [Full Text] [Related]
13. The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia.
Krysiak R; Gilowski W; Okopien B
Cardiovasc Ther; 2015 Oct; 33(5):270-4. PubMed ID: 26031507
[TBL] [Abstract][Full Text] [Related]
14. Lipid management in patients who have HIV and are receiving HIV therapy.
Aberg JA
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):207-22. PubMed ID: 19217520
[TBL] [Abstract][Full Text] [Related]
15. Dyslipidemia and lipid management in HIV-infected patients.
Lo J
Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):144-7. PubMed ID: 21297466
[TBL] [Abstract][Full Text] [Related]
16. [Fenofibrate].
Yamashita T; Nakamura H
Nihon Rinsho; 2001 Mar; 59 Suppl 3():618-24. PubMed ID: 11347142
[No Abstract] [Full Text] [Related]
17. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
18. [Part III. Clinical control of fenofibrate therapy].
Clin Investig Arterioscler; 2016 Jul; 28 Suppl 3():20-5. PubMed ID: 27473467
[No Abstract] [Full Text] [Related]
19. Dyslipidemia related to antiretroviral therapy.
Estrada V; Portilla J
AIDS Rev; 2011; 13(1):49-56. PubMed ID: 21412389
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus and renal transplantation.
Dinavahi RV; Mehrotra A; Murphy BT; Huprikar S
Kidney Int; 2009 Oct; 76(8):907-10. PubMed ID: 19494802
[No Abstract] [Full Text] [Related]
[Next] [New Search]